Semaglutide (Ozempic) and Tirzepatide (Mounjaro) are the newest and most requested group of drugs that have revolutionized weight loss treatment. These medications affect the part of the brain that suppress your appetite and signal you to feel full.
First Doctors Weight Loss Looks Beyond the Scales
Discover sustainable weight management with Semaglutide (Ozempic) and Tirzepatide (Mounjaro), integral parts of our comprehensive approach to weight loss and maintenance. Combined with our First Doctors Maintenance Program, these medications support achieving and maintaining your desired healthy weight—a crucial benefit for those with a history of dieting struggles.
Both Semaglutide (Ozempic) and Tirzepatide (Mounjaro) offer appetite suppression for effective obesity treatment and lower A1C in pre-diabetic patients. Ongoing research explores additional benefits like potential relief for sleep apnea (pending approval). These medications also help curb binge eating and manage eating impulses.
While both medications function similarly, Tirzepatide (Mounjaro) provides a slight edge by activating two hormone receptors, leading to a more pronounced appetite decrease compared to Semaglutide (Ozempic). Despite a slightly higher cost, its enhanced efficacy provides greater value.
